Evaluation of corneal damage after vitrectomy and effect of Rebamipide ocular solutio
Not Applicable
Completed
- Conditions
- dry eye
- Registration Number
- JPRN-UMIN000015888
- Lead Sponsor
- Mie University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
Patients that cannot make written informed consent.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To decrease postoperative dry eye syndrome after vitrectomy.
- Secondary Outcome Measures
Name Time Method Conjunctival goblet cell decrease after vitrectomy.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms does Rebamipide target to mitigate corneal damage post-vitrectomy?
How does Rebamipide ocular solution compare to standard-of-care treatments for dry eye after vitrectomy?
Are there specific biomarkers that predict corneal recovery in dry eye patients using Rebamipide?
What adverse events are associated with Rebamipide in post-vitrectomy dry eye management?
What combination therapies with Rebamipide are being explored for enhanced corneal repair in dry eye?